Loading...
XJPX
7062
Market cap11mUSD
Oct 09, Last price  
686.00JPY
1D
-0.15%
1Q
-9.86%
IPO
-80.40%
Name

Fureasu Co Ltd

Chart & performance

D1W1MN
XJPX:7062 chart
P/E
3.52
P/S
0.23
EPS
195.10
Div yield, %
—
Shrs. gr., 5y
2.06%
Rev. gr., 5y
15.77%
Revenues
7.64b
+0.72%
3,962,577,0003,672,197,0004,174,557,0004,584,081,0005,710,030,0007,582,581,0007,637,505,000
Net income
509m
P
56,879,00059,320,000147,853,00031,586,00058,305,000-244,549,000508,915,000
CFO
591m
P
-99,729,000-99,964,000309,270,000-233,145,000172,023,000-319,199,000590,563,000
Dividend
Mar 30, 202710.57 JPY/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Fureasu Co.,Ltd. is a Japanese company specializing in therapeutic massage services, massage franchise operations, and a diverse range of care solutions. Its therapeutic offerings encompass in-home acupuncture, moxibustion treatments, on-site corporate massage, and specialized support tailored for individuals with visual impairments. Beyond its bodywork segment, the company delivers a broad spectrum of in-home and institutional care services. This includes comprehensive small-scale multi-functional home nursing, domiciliary care visits, day-care transportation, and overnight respite programs. Fureasu also operates home-visit nursing services and manages medical care facilities, further providing personal care assistance for daily living activities like eating, excretion, and bathing. Established in 2000, Fureasu Co.,Ltd. is headquartered in Tokyo, Japan.

Key people

Taku Sawanobori
President, Chief Executive Officer, Representative Director · since 2024
Vice President, Chief Financial Officer, Director · since 2024
Jiro Kawakubo
Director · since 2025
Daitoku Nagata
Director · since 2025
Kazunori Nakamura
Chief Financial Officer, Director · since 2025
Masatake Miyoshi
Independent Director · since 2025
Yuzo Yoshida
Independent Director · since 2025
IPO date
Mar 28, 2019
Employees
Domiciled in
JP
Incorporated in
JP

Valuation

Title
JPY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2026‑032025‑032024‑032023‑032022‑032021‑032020‑032019‑032018‑032017‑03
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT